References
- 1. Samanek M. Congenital heart malformations: prevalence, severity, survival, and quality of life. Cardiol Young. 2000;10:179-185.
- 2. Blue GM, Kirk EP, Giannoulatou E, et al. Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease. J Am Coll Cardiol. 2014;64:2498-506. doi: 10.1016/j.jacc.2014.09.048.10.1016/j.jacc.2014.09.048
- 3. Fahed AC, Gelb BD, Seidman JG, Seidman CE. Genetics of Congenital Heart Disease. The glass half empty. Circ Res. 2013;112:707-720. doi: 10.1161/CIRCRESAHA.112.300853.10.1161/CIRCRESAHA.112.300853
- 4. Kuehl K, Loffredo C, lammer EJ, Iovannisci DM, Shaw GM. Association of Congenital Cardiovascular Malformations With 33 Single Nucleotide Polymorphisms of Selected Cardiovascular Disease-Related Genes. Birth Defects Res A Clin Mol Teratol. 2010;88:101-110. doi: 10.1002/bdra.20630.10.1002/bdra.20630
- 5. Pierpoint ME, Basson CT, Benson DW Jr, et al. Genetic Basis for Congenital Heart Defects: Current Knowledge. A scientific Statement From the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics. Circulation. 2007;115:3015-3038. doi: 10.1161/CIRCULATIONAHA.106.183056.10.1161/CIRCULATIONAHA.106.183056
- 6. Togănel R, Muntean I, Duicu C, Făgărăşan A, Gozar L, Bănescu C. The role of eNOS and AGT gene polymorphisms in secondary pulmonary arterial hypertension in Romanian children with congenital heart disease. Rev Romana Med Lab. 2013;21:267-274. doi: 10.2478/rrlm-2013-0031.10.2478/rrlm-2013-0031
- 7. Muntean I, Togănel R, Benedek T. Genetics of Congenital Heart Disease: Past and Present. Biochem Genet. 2017;55:105-123. doi: 10.1007/s10528-016-9780-7.10.1007/s10528-016-9780-7
- 8. Unolt M, Putotto C, Silvestri LM, et al. Transposition of great arteries: new insights into the pathogenesis. Front Pediatr. 2013;1:11. doi: 10.3389/fped.2013.00011.
- 9. De Luca A, Sarkozy A, Consoli F, et al. Familial transposition of the great arteries caused by multiple mutations in laterality genes. Heart. 2010;96:673-677. doi: 10.1136/hrt.2009.181685.10.1136/hrt.2009.181685
- 10. Villafane J, Lantin-Hermoso MR, Bhatt AB, et al. D-Transposition of the great arteries: Hot topics in the current era of the arterial switch operation. J Am Coll Cardiol. 2014;64:498-511. doi: 10.1016/j.jacc.2014.06.1150.
- 11. Sarris GE, Balmer C, Bonou P, et al. Clinical guidelines for the management of patients with transposition of the great arteries with intact ventricular septum. Cardiol Young. 2017;27:530-569. doi:10.1017/S1047951117000014.10.1017/S1047951117000014
- 12. Al-Ata JA. Balloon atrial septostomy in patient with dextrotransposition of the great arteries with insufficient mixing: 18 years of experience. JKAU: Med. Sci. 2010;17:73-89. doi: 10.4197/Med.17-4.6.10.4197/Med.17-4.6
- 13. Feltes TF, Bacha E, Beekman RH, et al. Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease A Scientific Statement From the American Heart Association. Circulation. 2011;123:2607-2652. doi: 10.1161/CIR.0b013e31821b1f10.10.1161/CIR.0b013e31821b1f10
- 14. Mukherjee D, Lindsay M, Zhang Y, et al. Analysis of 8681 neonates with transposition of the great arteries: outcomes with and without Rashkind balloon atrial septostomy. Cardiol Young. 2010;20:373-380. doi: 10.1017/S1047951110000296.10.1017/S1047951110000296
- 15. Peterson C, Ailes E, Riehle-Colarusso T, et al. Late detection of critical congenital heart disease among US infants. Estimation of the potential impact of proposed universal screening using pulse oxymetry. JAMA Pedaitrics. 2014;168:361-370. doi: 10.1001/jamapediatrics.2013.4779.10.1001/jamapediatrics.2013.4779
- 16. Jawin V, Ang H-L, Omar A, Thong M-K. Beyond Critical Congenital Heart Disease: Newborn Screening Using Pulse Oximetry for Neonatal Sepsis and Respiratory Diseases in a Middle-Income Country. PLoS ONE 2015;10:e0137580. doi: 10.1371/journal.pone.0137580.
- 17. Knowlles R, Griebsch I, Dezateux C, Brown J, Bull C, Wren C. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2005;9:1-152.
- 18. Eckersley L, Sadler L, Parry E, Finucane K, Gentles TL. Timing of diagnosis affects mortality in critical congenital heart disease. Arch Dis Child. 2016;101:516-520. doi: 10.1136/archdischild-2014-307691.10.1136/archdischild-2014-307691
- 19. Mahle WT, Gonzalez JH, Kreeger J, Marx G, Duldani G, Silverman NH. Echocardiography of transposition of the great arteries. Cardiol Young. 2012;22:664-670. doi: 10.1017/S1047951112001503.10.1017/S1047951112001503
- 20. Lopez L, Colan SD, Frommelt PC, et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the pediatric measurements writing group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr. 2010;23:465-495. doi: 10.1016/j.echo.2010.03.019.10.1016/j.echo.2010.03.019
- 21. Alwi M. Management algorithm in pulmonary atresia with intact ventricular septum. Catheter Cardiovasc Interv. 2006;67:679-686. doi: 10.1002/ccd.20672.10.1002/ccd.20672
- 22. Dodge-Khatami A, Ott S, Di Bernardo S, Berger F. Carotidsubclavian artery index: new echocardiographic index to detect coarctation in neonates and infants. Ann Thorac Surg. 2005;80:1652-1621. doi: 10.1016/j.athoracsur.2005.04.041.10.1016/j.athoracsur.2005.04.041
- 23. Amoozgar H, Salaminia S, Amirghofran AA, et al. Evaluation of cardiac and valvular function after arterial switch operation: a midterm follow-up. Int Cardiovasc Res J. 2013;7:83-89.
- 24. Suteu CC, Muntean I, Benedek T, Togănel R. Giant dissecting ventricular septal haematoma associated with critical congenital heart disease. Interact Cardiovasc Thorac Surg. 2016;23:837-838. doi: 10.1093/icvts/ivw223.10.1093/icvts/ivw223
- 25. Peng DM, Punn R, Maeda K, Selamet Tierney ES. Diagnosing Neonatal Aortic coarctation in the setting of Patent Ductus Arteriosus. Ann Thorac Surg. 2016;101:1005-1010. doi: 10.1016/j.athoracsur.2015.09.050.10.1016/j.athoracsur.2015.09.050
- 26. Mivelaz Y, Di Bernardo S, Meijboom EJ, Sekarski N. Validation of two echocardiographic indexes to improve the diagnosis of complex coarctations. Eur J Cardiothorac Surg. 2008;34:1051-1056. doi: 10.1016/j.ejcts.2008.07.036.10.1016/j.ejcts.2008.07.036
- 27. Lu CW, Wang JK, Chang CI, et al. Noninvasive diagnosis of aortic coarctation in neonates with patent ductus arteriosus. J Pediatr. 2006;148:217-221. doi: 10.1016/j.jpeds.2005.09.036.10.1016/j.jpeds.2005.09.036
- 28. Familiari A, Morlando M, Khalil AA, Sven-Erik S, et al. Risk factor for coarctation of the aorta on prenatal ultrasound: a systemic review and meta-analysis. Circulation. 2017;136:24. doi: 10.1161/CIRCULATIONAHA.116.024068.10.1161/CIRCULATIONAHA.116.024068
- 29. Mărginean C, Mărginean CO, Muntean I, Togănel R, Voidăzan S, Gozar L. The role of ventricular disproportion, aortic and ductal isthmus ultrasound measurements for the diagnosis of fetal aortic coarctation, in the third trimester of pregnancy. Med Ultrason. 2015;17:475-481. doi: 10.11152/mu.2013.2066.174.rvd.10.11152/mu.2013.2066.174.rvd
- 30. Daubeney PE, Sharland GK, Cook AC, Keeton BR, Anderson RH, Webber SA. Pulmonary atresia with intact ventricular septum: impact of fetal echocardiography on incidence at birth and postnatal outcome. UK and Eire Collaborative Study of Pulmonary Atresia with Intact Ventricular Septum. Circulation. 1998;98:562-566.10.1161/01.CIR.98.6.562
- 31. Peterson RE, Levi DS, Williams RJ, Lai WW, Sklansky MS, Drant S. Echocardiographic predictors of outcome in fetuses with pulmonary atresia with intact ventricular septum. J Am Soc Echocardiogr. 2006;19:1393-1400. doi: 10.1016/j.echo.2006.05.021l.10.1016/j.echo.2006.05.021l
- 32. Salvin JW, McElhinney DB, Colan SD, et al. Fetal tricuspid valve size and growth as predictors of outcome in pulmonary atresia with intact ventricular septum. Pediatrics. 2006;118:e415-e420. doi: 10.1542/peds.2006-0428.10.1542/peds.2006-0428
- 33. Graziano JN, Heidelberger KP, Ensing GJ, Gomez CA, Ludomirsky A. The influence of a restrictive atrial septal defect on pulmonary vascular morphology in patients with hypoplastic left heart syndrome. Pediatr Cardiol. 2002;23:146-151.10.1007/s00246-001-0038-7
- 34. Canter CE, Moorehead S, Huddleston CB, Spray TL. Restrictive atrial septal communication as a determinant of outcome of cardiac transplantation for hypoplastic left heart syndrome. Circulation. 1993;88:II456-II460.
- 35. Dash PK, Satpathy M. Atrial septal defect (secundum type). In: Sathpathy M, Mishra BR. Clinical Diagnosis of Congenital heart disease. Jaypee/The Health Sciences Publisher/New Delhi, 2015; p. 76-84.
- 36. Kuhn MA, Larsen RL, Mulla NF, Jofnston JK, Chinnock RE, Bailey LL. Outcome of infants with hypoplastic left heart syndrome who undergo atrial septostomy before heart transplantation. Am J Cardiol. 2000;85:124-127.